Advisor Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
RSCM
CAM
Advisor Group's LKFT Position: Q4 2019 in Review
Advisor Group increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 6.4% in Q4 2019, buying an estimated $44K and bringing the position to 3,941 shares worth $815K. The position accounts for 0.01% of the portfolio, ranked #1344.
Advisor Group first reported a position in LKFT in Q3 2016 and has held it in 14 quarters since. 137 funds tracked by Wall St. Rank hold LKFT as of Q4 2019.
- Advisor Group held 3,941 shares of Lakefront Biotherapeutics American Depositary Shares worth $815K as of Q4 2019.
- Advisor Group bought 238 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2019, an estimated $44K.
- Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Advisor Group's portfolio in Q4 2019, its #1344 holding.
- Advisor Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2016 and has held it in 14 quarters since.
- 137 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2019.
Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.